Cantor Fitzgerald's Pablo Zuanic hosted a virtual panel discussion about the psychedelics industry with three ketamine therapy providers: Irwin Naturals (OTC:IWINF)' CEO Klee Irwin, Field Trip H&W (OTC:FTHWF)'s co-founder and director Mujeeb Jafferi and Numinus (OTC:NUMIF)' CEO Payton Nyquvest.
See also: These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year
While all three interviewees seem to share similar views on most of the discussed topics, one thing seems certain: the mental health industry is increasingly more open to including PAT within the range of available treatments, as state...
Login or create a forever free account to read this news
Sign up/Log in